Notably, SALL4 negatively controls melanoma invasiveness-related genes, as for instance NGFR, a potent regulator of phenotype switching22, FN1, VEGFR-1, CDH2 (N-cadherin), and other genes implicated in melanoma invasiveness. This evidence concerns the gene CDH2 and melanoma.